(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) today announced the election of two new members to the CHPA Board of Directors during the association’s virtual November meeting. Newly elected CHPA board members include:
- Tim Grannan, President, Blistex Inc.
- Don Kerrigan, President, North America, The Nature’s Bounty Co.
Kerrigan was also elected to serve on the CHPA board’s executive committee.
“CHPA is delighted to welcome Tim and Don to its board of directors,” said CHPA President and CEO, Scott Melville. “CHPA’s expanded scope includes all three categories of personal healthcare — over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices — and these board appointments reflect the broad spectrum of companies we represent.”
Paul Gama, President of Personal Health Care for The Procter & Gamble Company, will continue serving as CHPA’s board chair until the Annual Executive Conference being held March 21-23, 2021.
“As Americans increasingly prioritize self-care for their health and wellness, the CHPA board plays an essential role in establishing our industry’s priorities and guiding the work of the association,” continued Melville. “We are fortunate to have industry executives like Don, Tim, and Paul volunteer to share their expertise and further elevate the governance of our association as well as the role of consumer healthcare in America.”
Also approved at the meeting were two new members to the CHPA Educational Foundation board, including:
- Jason Milligan, Marketing Director, Oral Health, GSK Consumer Health
- Daniella Foster, Vice President and Global Head, Public Affairs & Sustainability Consumer Health, Bayer Consumer Health
View the full CHPA Board of Directors.
View the full CHPA Educational Foundation Board of Directors.